The Injectable Drug Delivery conference will be hosting 2 interactive half day pre-conference workshops on the 15th May, presented by Human Factors Centre and Cambridge Consultants.
Building on the success of SMi's 10th Annual Flagship Conference Pre-Filled Syringes, we are thrilled to announce the launch of Injectable Drug Delivery.
Building on the success of SMi's 10th Annual Flagship Conference Pre-Filled Syringes, SMi are thrilled to present the launch of their Injectable Drug Delivery conference being held at Holiday Inn,
The US FDA announced today that it has cleared two novel gene therapies for sickle cell disease: Vertex Pharmaceuticals' Casgevy and bluebird bio's Lyfgenia.
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio